Occudo Quantitative Strategies LP Purchases New Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Occudo Quantitative Strategies LP acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 2,038 shares of the medical equipment provider's stock, valued at approximately $1,064,000.

Several other hedge funds have also recently made changes to their positions in the stock. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $488,000. OMERS ADMINISTRATION Corp raised its holdings in shares of Intuitive Surgical by 9.0% during the fourth quarter. OMERS ADMINISTRATION Corp now owns 25,671 shares of the medical equipment provider's stock valued at $13,399,000 after purchasing an additional 2,119 shares during the last quarter. MayTech Global Investments LLC raised its holdings in shares of Intuitive Surgical by 5.2% during the fourth quarter. MayTech Global Investments LLC now owns 68,064 shares of the medical equipment provider's stock valued at $35,527,000 after purchasing an additional 3,345 shares during the last quarter. MJP Associates Inc. ADV raised its holdings in shares of Intuitive Surgical by 29.5% during the fourth quarter. MJP Associates Inc. ADV now owns 1,054 shares of the medical equipment provider's stock valued at $550,000 after purchasing an additional 240 shares during the last quarter. Finally, Integral Health Asset Management LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $20,878,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ISRG has been the subject of several research reports. Robert W. Baird decreased their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Evercore ISI cut their target price on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research report on Wednesday, April 23rd. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, April 14th. Finally, Erste Group Bank lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 17th. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $598.95.

Intuitive Surgical Stock Performance

Shares of ISRG traded up $3.32 during mid-day trading on Friday, reaching $563.60. The stock had a trading volume of 1,422,176 shares, compared to its average volume of 1,640,855. The firm has a market cap of $202.00 billion, a price-to-earnings ratio of 87.93, a PEG ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 12 month low of $393.98 and a 12 month high of $616.00. The business has a fifty day moving average of $505.22 and a 200 day moving average of $536.45.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the prior year, the business earned $1.50 earnings per share. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling

In related news, EVP Brian Edward Miller sold 8,900 shares of the company's stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. This represents a 60.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. This represents a 68.85% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 32,700 shares of company stock worth $16,865,621. 0.70% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.